Advertisement

Stroke and Cognitive Disorder in Women

  • Mia von EulerEmail author
Chapter

Abstract

Women have a higher prevalence of stroke at an older age compared to men. Atrial fibrillation (AF) and diabetes have a higher mortality and stroke risk in women than in men. Migraine with aura is twice to four times as common in women than in men and doubles the risk of stroke. A previous history of preeclampsia is an independent female-specific risk factor for stroke. The use of hormonal therapy (HT) in menopause also increases stroke risk. Women may have more speech difficulties at onset of stroke, which may delay hospital referral. This chapter updates our knowledge on sex- and gender differences in stroke.

Keywords

Atrial fibrillation (AF) Carotid stenosis CHA2DS2-VASc risk score Cognitive decline Dementia Depression Hormone replacement therapy (HRT) Menopause Migraine Migraine with aura Novel oral anticoagulants (NOACs) Oral contraceptives Preeclampsia Stroke Thrombectomy Thrombolysis Traditional risk factors Transitory ischemic attack (TIA) 

References

  1. 1.
    Arnao V, Acciarresi M, Cittadini E, Caso V. Stroke incidence, prevalence and mortality in women worldwide. Int J Stroke. 2016;11:287–301.CrossRefPubMedGoogle Scholar
  2. 2.
    Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. The lifetime risk of stroke: estimates from the Framingham study. Stroke. 2006;37:345–50.CrossRefPubMedGoogle Scholar
  3. 3.
    Kolominsky-Rabas PL, Wiedmann S, Weingärtner M, Liman TG, Endres M, Schwab S, Buchfelder M, Heuschmann PU. Time trends in incidence of pathological and etiological stroke subtypes during 16 years: the Erlangen Stroke Project. Neuroepidemiology. 2015;44(1):24–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, Wolf PA. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA. 2006;296:2939–46.CrossRefPubMedGoogle Scholar
  5. 5.
    Heuschmann PU, Grieve AP, Toschke AM, Rudd AG, Wolfe CD. Ethnic group disparities in 10-year trends in stroke incidence and vascular risk factors: the South London Stroke Register (SLSR). Stroke. 2008;39:2204–10.CrossRefPubMedGoogle Scholar
  6. 6.
    Wieberdink RG, Ikram MA, Hofman A, Koudstaal PJ, Breteler MM. Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008. Eur J Epidemiol. 2012;27:287–95.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Rosengren A, Giang KW, Lappas G, Jern C, Torén K, Björck L. Twenty-four-year trends in the incidence of ischemic stroke in Sweden from 1987 to 2010. Stroke. 2013;44:2388–93.CrossRefPubMedGoogle Scholar
  8. 8.
    World Health Organisation. Cerebrovascular disorders (offset publications). Geneva: World Health Organization; 1978. isbn:978-92-4-170043-2.Google Scholar
  9. 9.
    Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami TS, Higashida RT, Johnston SC, Kidwell CS, Lutsep HL, Miller E, Sacco RL, American Heart Association, American Stroke Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular Nursing, Interdisciplinary Council on Peripheral Vascular Disease. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40:2276–93.CrossRefPubMedGoogle Scholar
  10. 10.
    Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke. 2009;40:1032–7.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, Redgrave JN, Bull LM, Welch SJ, Cuthbertson FC, Binney LE, Gutnikov SA, Anslow P, Banning AP, Mant D, Mehta Z. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet. 2005;366:1773–83.CrossRefPubMedGoogle Scholar
  12. 12.
    Haberman S, Capildeo R, Rose FC. Sex differences in the incidence of cerebrovascular disease. J Epidemiol Community Health. 1981;35:45–50.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Nilsson OG, Lindgren A, Ståhl N, Brandt L, Säveland H. Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. J Neurol Neurosurg Psychiatry. 2000;69:601–7.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Jacobs BS, Boden-Albala B, Lin IF, Sacco RL. Stroke in the young in the Northern Manhattan Stroke Study. Stroke. 2002;33:2789–93.CrossRefPubMedGoogle Scholar
  15. 15.
    Appelros P, Jonsson F, Asplund K, Eriksson M, Glader EL, Asberg KH, Norrving B, Stegmayr B, Terént A, Riks-Stroke Collaboration. Trends in baseline patient characteristics during the years 1995–2008: observations from risk-stroke, the Swedish Stroke Register. Cerebrovasc Dis. 2010;30:114–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–e245.CrossRefPubMedGoogle Scholar
  17. 17.
    Mendis S. Prevention and care of stroke in low- and middle-income countries; the need for a public health perspective. Int J Stroke. 2010;5:86–91.CrossRefPubMedGoogle Scholar
  18. 18.
    de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78:1365–72.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Kleindorfer D, Broderick J, Khoury J, Flaherty M, Woo D, Alwell K, Moomaw CJ, Schneider A, Miller R, Shukla R, Kissela B. The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke. 2006;37:2473–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Wardlaw JM, White PM. The detection and management of unruptured intracranial aneurysms. Brain. 2000;123:205–21.CrossRefPubMedGoogle Scholar
  21. 21.
    Algra AM, Klijn CJ, Helmerhorst FM, Algra A, Rinkel GJ. Female risk factors for subarachnoid hemorrhage: a systematic review. Neurology. 2012;79:1230–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Levine DA, Galecki AT, Langa KM, Unverzagt FW, Kabeto MU, Giordani B, Wadley VG. Trajectory of cognitive decline after incident stroke. JAMA. 2015;314:41–51.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Liebetrau M, Steen B, Skoog I. Stroke in 85-year-olds: prevalence, incidence, risk factors, and relation to mortality and dementia. Stroke. 2003;34:2617–22.CrossRefPubMedGoogle Scholar
  24. 24.
    Zhu L, Fratiglioni L, Guo Z, Winblad B, Viitanen M. Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen project. Neurology. 2000;54:2103–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Feigin VL, Krishnamurthi RV, Parmar P, et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990–2013: the GBD 2013 study. Neuroepidemiology. 2015;45:161–76.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Wu YT, Fratiglioni L, Matthews FE, et al. Dementia in Western Europe: epidemiological evidence and implications for policy making. Lancet Neurol. 2016;15:116–24.CrossRefPubMedGoogle Scholar
  27. 27.
    Satizabal CL, Beiser AS, Chouraki V, Chene G, Dufouil C, Seshadri S. Incidence of dementia over three decades in the Framingham Heart Study. N Engl J Med. 2016;374:523–32.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277:813–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Langa KM, Levine DA. The diagnosis and management of mild cognitive impairment: a clinical review. JAMA. 2014;312:2551–61.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Cooper LL, Woodard T, Sigurdsson S, van Buchem MA, Torjesen AA, Inker LA, Aspelund T, Eiriksdottir G, Harris TB, Gudnason V, Launer LJ, Mitchell GF. Cerebrovascular damage mediates relations between aortic stiffness and memory. Hypertension. 2016;67:176–82.CrossRefPubMedGoogle Scholar
  31. 31.
    Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL, Howard VJ, Lichtman JH, Lisabeth LD, Piña IL, Reeves MJ, Rexrode KM, Saposnik G, Singh V, Towfighi A, Vaccarino V, Walters MR, American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council for High Blood Pressure Research. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1545–88.CrossRefPubMedGoogle Scholar
  32. 32.
    O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Damasceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S, INTERSTROKE Investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376:112–23.CrossRefPubMedGoogle Scholar
  33. 33.
    Peters SA, Huxley RR, Woodward M. Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke. 2013;44:2821–8.CrossRefPubMedGoogle Scholar
  34. 34.
    Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, Perkovic V, Li N, MacMahon S, Blood Pressure Lowering Treatment Trialists’ Collaboration. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29(21):2669–80.CrossRefPubMedGoogle Scholar
  35. 35.
    Neovius M, Janson A, Rössner S. Prevalence of obesity in Sweden. Obes Rev. 2006;7:1–3.CrossRefPubMedGoogle Scholar
  36. 36.
    Giampaoli S, Palmieri L, Donfrancesco C, Lo Noce C, Pilotto L, Vanuzzo D, Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey Research Group. Cardiovascular health in Italy. Ten-year surveillance of cardiovascular diseases and risk factors: Osservatorio Epidemiologico Cardiovascolare/Health Examination Survey 1998-2012. Eur J Prev Cardiol. 2015;22:9–37.CrossRefPubMedGoogle Scholar
  37. 37.
    Friberg L, Bergfeldt L. Atrial fibrillation prevalence revisited. J Intern Med. 2013;274(5):461–8.CrossRefPubMedGoogle Scholar
  38. 38.
    Go AS, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA. 2001;285:2370–5.CrossRefPubMedGoogle Scholar
  39. 39.
    Heeringa J, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27(8):949–53.CrossRefPubMedGoogle Scholar
  40. 40.
    Michelena HI, Powell BD, Brady PA, Friedman PA, Ezekowitz MD. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042–6.CrossRefGoogle Scholar
  41. 41.
    Emdin CA, Wong CX, Hsiao AJ, Altman DG, Peters SA, Woodward M, Odutayo AA. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ. 2016;53:h7013.CrossRefGoogle Scholar
  42. 42.
    Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–962.Google Scholar
  43. 43.
    Conolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51.CrossRefGoogle Scholar
  44. 44.
    Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91.CrossRefPubMedGoogle Scholar
  45. 45.
    Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–92.CrossRefPubMedGoogle Scholar
  46. 46.
    Hendriks SH, van Hateren KJ, Groenier KH, Houweling ST, Maas AH, Kleefstra N, Bilo HJ. Sex differences in the quality of diabetes care in the Netherlands (ZODIAC-45). PLoS One. 2015;10:e0145907.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Kurth T, Winter AC, Eliassen AH, Dushkes R, Mukamal KJ, Rimm EB, Willett WC, Manson JE, Rexrode KM. Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ. 2016;353:i2610.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Tepper NK, Whiteman MK, Zapata LB, Marchbanks PA, Curtis KM. Safety of hormonal contraceptives among women with migraine: a systematic review. Contraception. 2016;94(6):630–40.CrossRefPubMedGoogle Scholar
  49. 49.
    MacClellan LR, Giles W, Cole J, Wozniak M, Stern B, Mitchell BD, Kittner SJ. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke. 2007;38:2438–45.CrossRefPubMedGoogle Scholar
  50. 50.
    Brayfield A. Martindale the complete drug reference. 38th ed. New York: Pharmaceutical Press; 2014. isbn:978-0-85711-139-5.Google Scholar
  51. 51.
    Boardman HM, Hartley L, Eisinga A, Main C, Roqué i Figuls M, Bonfill Cosp X, Gabriel Sanchez R, Knight B. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2015;3:CD002229.Google Scholar
  52. 52.
    Nelson HD, Walker M, Zakher B, Mitchell J. Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations. Ann Intern Med. 2012;157:104–13.CrossRefPubMedGoogle Scholar
  53. 53.
    Grodstein F, Manson JE, Stampfer MJ, Rexrode K. Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch Intern Med. 2008;168:861–6.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Chan W-S, Ray J, Wai EK, Ginsburg S, Hannah ME, Corey PN, Ginsberg JS. Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence. Arch Intern Med. 2004;164:741–7.CrossRefPubMedGoogle Scholar
  55. 55.
    Baillargeon JP, McClish DK, Essah PA, Nestler JE. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab. 2005;90:3863–70.CrossRefPubMedGoogle Scholar
  56. 56.
    Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366(24):2257–66.CrossRefPubMedGoogle Scholar
  57. 57.
    WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischaemic stroke and combined oral contraceptives: results of an international, multicenter, case-control study. Lancet. 1996;348:498–505.CrossRefGoogle Scholar
  58. 58.
    WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicenter, case-control study. Lancet. 1996;348:505–10.CrossRefGoogle Scholar
  59. 59.
    Kemmeren JM, Tanis BC, van den Bosch MA, Bollen EL, Helmerhorst FM, van der Graaf Y, Rosendaal FR, Algra A. Risk of arterial thrombosis in relation to oral contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke. 2002;33:1202–8.CrossRefPubMedGoogle Scholar
  60. 60.
    Slooter AJ, Rosendaal FR, Tanis BC, Kemmeren JM, van der Graaf Y, Algra A. Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke. J Thromb Haemost. 2005;3:1213–7.CrossRefPubMedGoogle Scholar
  61. 61.
    Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol. 2009;8:998–1005.CrossRefPubMedGoogle Scholar
  62. 62.
    Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2013;7:CD001449.Google Scholar
  63. 63.
    Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014;2:CD002252.Google Scholar
  64. 64.
    European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L, ESC Committee for Practice Guidelines. ESC guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147–97.CrossRefGoogle Scholar
  65. 65.
    McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156:918–30.CrossRefPubMedGoogle Scholar
  66. 66.
    Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2014;6:CD001059.Google Scholar
  67. 67.
    WHO Recommendations. http://www.who.int/elena/titles/calcium_pregnancy/en/. Accessed 31 Jul 2016.
  68. 68.
    Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;2:CD004659.Google Scholar
  69. 69.
    Leffert LR, Clancy CR, Bateman BT, Cox M, Schulte PJ, Smith EE, Fonarow GC, Kuklina EV, George MG, Schwamm LH. Treatment patterns and short-term outcomes in ischemic stroke in pregnancy or postpartum period. Am J Obstet Gynecol. 2016;214:723.e1–11.CrossRefGoogle Scholar
  70. 70.
    Dentali F, Poli D, Scoditti U, Di Minno MN, De Stefano V, Siragusa S, Kostal M, Palareti G, Sartori MT, Grandone E, Vedovati MC, Ageno W, CErebral VEin Thrombosis International Study Investigators, Falanga A, Lerede T, Bianchi M, Testa S, Witt D, McCool K, Bucherini E, Grifoni E, Coalizzo D, Benedetti R, Marietta M, Sessa M, Guaschino C, di Minno G, Tufano A, Barbar S, Malato A, Pini M, Castellini P, Barco S, Barone M, Paciaroni M, Alberti A, Agnelli G, Giorgi Pierfranceschi M, Dulicek P, Silingardi M, Federica L, Ghirarduzzi A, Tiraferri E, di Lazzaro V, Rossi E, Ciminello A, Pasca S, Barillari G, Rezoagli E, Galli M, Squizzato A, Tosetto A. Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost. 2012;10:1297–302.CrossRefPubMedGoogle Scholar
  71. 71.
    Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664–70.CrossRefPubMedGoogle Scholar
  72. 72.
    Berglund A, Svensson L, Wahlgren N, von Euler M, HASTA Collaborators. Face arm speech time test use in the prehospital setting, better in the ambulance than in the emergency medical communication center. Cerebrovasc Dis. 2014;37:212–6.CrossRefPubMedGoogle Scholar
  73. 73.
    Mochari-Greenberger H, Xian Y, Hellkamp AS, Schulte PJ, Bhatt DL, Fonarow GC, Saver JL, Reeves MJ, Schwamm LH, Smith EE. Racial/ethnic and sex differences in emergency medical services transport among hospitalized US stroke patients: analysis of the national get with the guidelines-stroke registry. J Am Heart Assoc. 2015;4:e002099.CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Berglund A, von Euler M, Schenck-Gustafsson K, Castrén M, Bohm K. Identification of stroke during the emergency call: a descriptive study of callers’ presentation of stroke. BMJ Open. 2015;5:e007661.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Lisabeth LD, Brown DL, Hughes R, Majersik JJ, Morgenstern LB. Acute stroke symptoms: comparing women and men. Stroke. 2009;40:2031–6.CrossRefPubMedGoogle Scholar
  76. 76.
    Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke. 2005;36:62–5.CrossRefPubMedGoogle Scholar
  77. 77.
    Nathanson D, Patrone C, Nyström T, von Euler M. Sex, diastolic blood pressure, and outcome after thrombolysis for ischemic stroke. Stroke Res Treat. 2014;2014:747458.PubMedPubMedCentralGoogle Scholar
  78. 78.
    Hill MD, Kent DM, Hinchey J, Rowley H, Buchan AM, Wechsler LR, Higashida RT, Fischbein NJ, Dillon WP, Gent M, Firszt CM, Schulz GA, Furlan AJ, PROACT-2 Investigators. Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke. 2006;37:2322–5.CrossRefPubMedGoogle Scholar
  79. 79.
    Meseguer E, Mazighi M, Labreuche J, Arnaiz C, Cabrejo L, Slaoui T, Guidoux C, Olivot JM, Abboud H, Lapergue B, Raphaeli G, Klein IF, Lavallée PC, Amarenco P. Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic review. Stroke. 2009;40:2104–10.CrossRefPubMedGoogle Scholar
  80. 80.
    Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, Dávalos A, Majoie CB, van der Lugt A, de Miquel MA, Donnan GA, Roos YB, Bonafe A, Jahan R, Diener HC, van den Berg LA, Levy EI, Berkhemer OA, Pereira VM, Rempel J, Millán M, Davis SM, Roy D, Thornton J, Román LS, Ribó M, Beumer D, Stouch B, Brown S, Campbell BC, van Oostenbrugge RJ, Saver JL, Hill MD, Jovin TG, HERMES Collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387:1723–31.CrossRefPubMedGoogle Scholar
  81. 81.
    Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2007;4:CD000197.Google Scholar
  82. 82.
    Hsue PY, Bittner VA, Betteridge J, Fayyad R, Laskey R, Wenger NK, Waters DD. Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials. Am J Cardiol. 2015;115:447–53.CrossRefPubMedGoogle Scholar
  83. 83.
    Hedayati N, Humphries MD, Zhou W. Gender and outcomes of carotid artery interventions. Vasc Endovasc Surg. 2014;48:99–105.CrossRefGoogle Scholar
  84. 84.
    Luebke T, Brunkwall J. Meta-analysis and meta-regression analysis of the associations between sex and the operative outcomes of carotid endarterectomy. BMC Cardiovasc Disord. 2015;15:32.CrossRefPubMedPubMedCentralGoogle Scholar
  85. 85.
    De Rango P, Brown MM, Leys D, Howard VJ, Moore WS, Paciaroni M, Ringleb P, Rockman C, Caso V. Management of carotid stenosis in women: consensus document. Neurology. 2013;80:2258–68.CrossRefPubMedPubMedCentralGoogle Scholar
  86. 86.
    Buratti L, Balestrini S, Avitabile E, Altamura C, Vernieri F, Viticchi G, Falsetti L, Provinciali L, Silvestrini M. Sex-associated differences in the modulation of vascular risk in patients with asymptomatic carotid stenosis. J Cereb Blood Flow Metab. 2015;35(4):684–8.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal cognitive assessment, MoCa: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.CrossRefPubMedGoogle Scholar
  88. 88.
    Lin JS, O’Connor E, Rossom RC, Perdue LA, Burda BU, Thompson M, Eckstrom E. Screening for cognitive impairment in older adults: a systematic review for the U.S. preventive services task force. Ann Intern Med. 2013;159(9):601–12.PubMedGoogle Scholar
  89. 89.
    Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2014;7:CD000213.PubMedCentralGoogle Scholar
  90. 90.
    Emberson J, Lees KR, Blackwell L, Albers G, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384:1929–35.CrossRefPubMedPubMedCentralGoogle Scholar
  91. 91.
    IST-3 Collaborative Group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012;379:2352–63.CrossRefGoogle Scholar
  92. 92.
    Reeves M, Bhatt A, Jajou P, Brown M, Lisabeth L. Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis. Stroke. 2009;40:1743–9.CrossRefPubMedGoogle Scholar
  93. 93.
    Shobha N, Sylaja PN, Kapral MK, Fang J, Hill MD, Investigators of the Registry of the Canadian Stroke Network. Differences in stroke outcome based on sex. Neurology. 2010;74:767–71.CrossRefPubMedPubMedCentralGoogle Scholar
  94. 94.
    Nagaraja N, Bhattacharya P, Mada F, Salowich-Palm L, Hinton S, Millis S, et al. Gender based differences in acute stroke care in Michigan hospitals. J Neurol Sci. 2012;314:88–91.CrossRefPubMedGoogle Scholar
  95. 95.
    Berglund A, Svensson L, Sjöstrand C, von Arbin M, von Euler M, Wahlgren N, HASTA Collaborators, Engerström L, Höjeberg B, Käll TB, Mjörnheim S, Engqvist A. Higher prehospital priority level of stroke improves thrombolysis frequency and time to stroke unit: the Hyper Acute STroke Alarm (HASTA) study. Stroke. 2012;43:2666–70.CrossRefPubMedGoogle Scholar
  96. 96.
    Puolakka T, Väyrynen T, Häppölä O, Soinne L, Kuisma M, Lindsberg PJ. Sequential analysis of pretreatment delays in stroke thrombolysis. Acad Emerg Med. 2010;17:965–9.CrossRefPubMedGoogle Scholar
  97. 97.
    Rothwell PM, Algra A, Chen Z, Diener HC, Norrving B, Mehta Z. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet. 2016;388:365–75.CrossRefPubMedPubMedCentralGoogle Scholar
  98. 98.
    Sandercock PA, Counsell C, Tseng MC, Cecconi E. Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014;3:CD000029.Google Scholar
  99. 99.
    Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2013;9:CD000197.Google Scholar
  100. 100.
    Tsivgoulis G, Katsanos AH, Butcher KS, Boviatsis E, Triantafyllou N, Rizos I, Alexandrov AV. Intensive blood pressure reduction in acute intracerebral hemorrhage: a meta-analysis. Neurology. 2014;83:1523–9. Erratum in: Neurology. 2015;84:2466CrossRefPubMedGoogle Scholar
  101. 101.
    Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–67.CrossRefPubMedGoogle Scholar
  102. 102.
    European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457–507.CrossRefGoogle Scholar
  103. 103.
    Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN, Wentworth D, American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2011;42:227–76.CrossRefPubMedGoogle Scholar
  104. 104.
    Howard G, Roubin GS, Jansen O, Hendrikse J, Halliday A, Fraedrich G, Eckstein HH, Calvet D, Bulbulia R, Bonati LH, Becquemin JP, Algra A, Brown MM, Ringleb PA, Brott TG, Mas JL, Carotid Stenting Trialists’ Collaboration. Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials. Lancet. 2016;387:1305–11.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of Clinical Science and EducationKarolinska Institutet Stroke Research Network, SödersjukhusetStockholmSweden
  2. 2.Section of Neurology, Department of Internal MedicineSödersjukhusetStockholmSweden
  3. 3.Department of Clinical PharmacologyKarolinska University HospitalStockholmSweden

Personalised recommendations